Sentences with phrase «as pharmaceutical development»
The Diplomates of the following Specialty Boards usually work in university research departments at veterinary and medical colleges, in industries such as pharmaceutical development and food production, and as consultants available to your family veterinarian for consultations to improve your pet's healthcare.
http://allpetcareanimalhospital.com/ Not exact matches
But, as part of Beijing's «Made in China 2025» industry plan, President Xi Jinping identified the pharmaceutical sector as one to push, with the focus on innovation and homegrown research and development.
The CRO industry is undergoing a wave of consolidation as pharmaceutical companies strive to cut costs, reduce clinical trial times and expand their research and development presence.
From 2010 through the approvals of Kyprolis ® and Stivarga ® and its acquisition by Amgen in October 2013, he was Vice President, Corporate Development and Strategy at Onyx Pharmaceuticals (NASDAQ: ONXX), where he served as Head of Strategy and Strategic Asset Management, and Head of Transactions.
The takeover interest in Tesaro underscores the pharmaceutical industry's strong appetite for the acquisition of biotechnology companies with promising medicines under development in lucrative sectors such as cancer treatment.
Prior to that, Dr. Armstrong served as Senior Vice President at Merck Serono, Executive Vice President Product Development at Bayer AG, and Senior Vice President Medical Research at Zeneca Pharmaceuticals (now AstraZeneca).
As Poppe put it: «Valeant and the chief executive [Michael Pearson] had a good insight, which is that the U.S. pharmaceutical industry was spending a lot of money on [research and development] and not getting a great return on original research and development ideas.»
What looks like a bubble at first glance can be viewed as a long - term strategy for funding drug development, one that involves private funds, pharmaceutical companies and the public markets, along with a good deal of risk — and, sometimes, high reward.
Since its foundation in 1946, Taiyo has established itself as a leader in the development and production of emulsifiers, stabilizers, egg and tea based ingredients, and highly functional ingredients for the food and pharmaceutical industries.
METTLER TOLEDO is also one of the top three providers of various related measurement technologies as well as a leading vendor of systems for automated pharmaceutical research and the development of active ingredients.
He was formerly employed by H.J. Heinz as a food technologist responsible for product and process development, and has consulted for the food and pharmaceutical industries.
But her mysteries also delve into moregeneral topics such as community development, pharmaceutical research, theenvironment and family dynamics.
As neurological disorders affect approximately one - third of the U.S. population, and pharmaceutical firms are largely abandoning their research and development efforts in neuroscience, the work of academic research institutions is crucial in the effort to drive innovation and discovery in this field.
I signed a 1 - year contract as an analytical chemist in pharmaceutical development at a well - known multinational company.
As a pharmaceutical sciences Ph.D., you may be able to contribute to the development and operation of similar new business opportunities.
In addition to a socially responsible mission, other advantages of working in the biotechnology and pharmaceutical industry, as identified by survey takers, were: engaging work and being part of cutting - edge research and development; innovative, creative, and fast - paced work; and stability in difficult economic times, including generous salaries, benefits, and job security.
Despite all the changes, pharmaceutical companies are maintaining a strong internal development program in areas with large markets such as oncology, neuroscience, and diabetes / obesity; and they are hiring people whose skills fit with their drug - development programs.
«With the headcount constraints in today's economic climate, industry needs to hire leaders as well as technically excellent scientists,» says Scott Reines, newly retired vice president of pharmaceutical research and development at Johnson & Johnson, a pharmaceutical company based in New Brunswick, New Jersey.
Choosing a career in industry may seem risky at a time when the pharmaceutical industry has shed many scientific jobs as a result of the global recession and looming restructuring of the drug - development process.
And, much as in airplane or pharmaceutical development, government decisions will determine whether these reactors succeed.
The incoming AAAS Public Engagement Fellows work in such varied disciplines as virology, vaccine and pharmaceutical development, public health, demography, disease ecology, environmental health, parasitology, and human and veterinary epidemiology.
This is what is known as idiosyncratic toxicity and is a big headache for the pharmaceutical industry, as it tends to be detected in late development stages of the drug and even when it is already on the market, often causing the drug to be withdrawn.
In a study being published in the journal Neuron, researchers show that the signal molecule TGF - beta acts as a time signal that regulates the nerve stem cells» potential at different stages of the brain's development — knowledge that may be significant for future pharmaceutical development.
They cite the example of TransCelerate BioPharma, a group of 10 major pharmaceutical companies that came together to share and direct resources toward selected priorities in order to improve the efficiency of drug development, such as clinical trial site qualification standards.
Existing regional strengths include the aerospace and agrifood industries; advanced manufacturing; creative and cultural enterprises such as design, music, and entertainment; sustainable transportation in the automotive and boating industries; and health care, including pharmaceuticals, biotechnology, and medical device development.
Bristol - Myers Squibb won its citation «for extending and enhancing human life through innovative pharmaceutical research and development, and for redefining the science of clinical study through groundbreaking and extremely complex clinical trials that are now recognized as industry models.»
These include various investments in R&D, manufacturing, and process development by giant pharmaceutical companies such as Norvartis, Eli Lilly, GlaxoSmithKline, Baxter, and Merck Sharp & Dohme.
Dr Kollmannsberger said: «The quantification we developed could be useful in assessing bone quality during physiological development or pathological conditions of age, disease and pharmaceutical intervention, complementary to existing measures such as bone mineral density.
Snyder hopes such partnerships, combined with the emergence of small companies that serve as drug - development innovators, will allow the pharmaceutical industry to rebound and create new jobs.
Patrick Vallance, president of research and development at the pharmaceutical giant GlaxoSmithKline, has been appointed as chief scientific adviser, the UK government announced on 8 November.
The Bill & Melinda Gates Foundation announced today that Trevor Mundel, who currently heads the development team of pharmaceutical giant Novartis International AG, will take over as president of the its Global Health Program on 1 December.
The Chinese Academy of Sciences has similarly attracted Western scientists who are co-powering progress in such fields as «electric vehicles, integrated circuits, pharmaceutical development, and computer science.»
Hui Huang, the Canadian - educated director of the Visual Computing Center, says the Chinese Academy of Sciences has similarly attracted Western scientists who are co-powering progress in such fields as «electric vehicles, integrated circuits, pharmaceutical development, and computer science.»
«The development of this microfluidic lung model, as well as other organs - on - chip, holds the promise of improving the physiological relevance of cellular models for more accurate prediction of the effects of toxicants and drugs on humans, and for reducing the use of animals in medical and pharmaceutical research,» said Sonia Grego, Ph.D., research scientist at RTI and the project's principal investigator.
«Our main goal, as the premier genomics laboratory of the Department of Defense, was to advise policymakers, the medical community, and those involved in the development of pharmaceuticals on the effects viral evolution might have on medical countermeasures as a consequence of the sustained human - to - human transmission during the Ebola outbreak in western Africa,» Palacios said.
Most recently, Dr. Kanner served as Vice President of Discovery Biology at Arrowhead Pharmaceuticals, where he helped lead the discovery and development of novel RNAi - based therapeutics for oncology and genetic disease programs.
As a result, Moderna's platform has the potential to speed the development and manufacture of treatments for many diseases that are currently untreatable with existing pharmaceutical approaches.
Newly appointed CEO of Novartis, Vas Narasimhan has his sights set on the gene therapy area as the next big development in the pharmaceutical industry.
Since that post, there have been exciting developments in the progress of the two most advanced of these immunotherapies: PD01A, the AS - targeting active vaccine from Austrian biotechnology startup AFFiRiS AG, developed using its patented «AFFITOME» neo-antigen discovery platform of molecular mimicry; and PRX002, a humanized monoclonal Ab (mAb) under development from Prothena Corp PLC, the successor of aggregate - clearing immunotherapy pioneer Élan Pharmaceuticals.
As our non-pharmaceutical products continue to generate revenue they will help support our financial position and the development of our pharmaceutical products.
These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
Baylor currently serves as President and CEO of Biologics Consulting, a regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices based in Alexandria, VA..
Again, these experiments clearly highlight that PTP1B could be a very important player in the development of insulin resistance, and this has actually led to a number of pharmaceutical companies developing drugs, trying to develop inhibitors of PTP1B as potential drugs for treatment of obesity and type II diabetes.
Afterwards, Tom spent two years working at LigoCyte pharmaceuticals, where he served as Director of Process Development and Project Leader in the Norovirus vaccine program.
These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
The CIC was founded in 2002 as an international association of pharmaceutical and biotechnology companies and academic institutions with a common interest in immunotherapy research and development with the ultimate goal of making cancer immunotherapies part of the standard - of - care in oncology.
The SMA Foundation serves as the hub and clearinghouse of information for the diverse universes involved in drug development, including pharmaceutical and biotech companies, academia, non-profits, clinicians, patients, government / regulators, and the media.
As Head of Project Leader Unit, Nicolas is in charge of the pharmaceutical development and subsequent production of vaccines - for use in clinical trials - directly funded by the European Vaccine Initiative (EVI), and European projects funded from other sources coordinated by EVI.
Now, a major deal between Isis Pharmaceuticals and drug giant Roche promises to support the development of one kind of gene silencing drug, called ASOs, taking them through to clinical trials in patients as quickly and efficiently as possible.
It's commonly used for environmental and health analyses, as well as by industry for pharmaceutical and petrochemical product development.